Advisory Panel
⦿ J Alexander Bodkin (ac) ⦿ Jonathan Davidson (ac) ⦿ John Finberg (ac) ⦿ Wegdan Rashad (ac) ⦿ Clare Stanford (ac) ⦿ Michael Thase (ac) ⦿ Eduard Vieta (c)
Presiding Council
⦿ Chittaranjan Andrade ⦿ David Nutt ⦿ Gordon Parker ⦿ Elliott Richelson ⦿ Stephen Stahl ⦿ Allan Young ⦿ Michael Berk (vc) ⦿ Ken Gillman (c)
Tempus perficit circulum, vetus renovatur
About Us
The International MAOI Expert Group unites clinicians and researchers with specific expertise in the pharmacology and clinical use of the classic monoamine oxidase inhibitor (MAOI) antidepressants (phenelzine, tranylcypromine, isocarboxazid). The Group has recently authored two Prescriber’s Guides on MAOI treatment and on the MAOI diet—these are comprehensive, state-of-the-art guidelines based on high-quality clinical evidence complemented by a broad expert consensus; together, these sister publications have set a new benchmark in the field of MAOI research, with directly applicable treatment recommendations for clinical practice.
Core Publications
— Van den Eynde V, Abdelmoemin WR, Abraham MM, et al. The prescriber’s guide to classic MAO inhibitors (phenelzine, tranylcypromine, isocarboxazid) for treatment-resistant depression. CNS Spectrums. 2022:1-14.
The Prescriber's Guide to the MAOI Diet-Thinking Through Tyramine Troubles
— Van den Eynde V, Gillman PK, Blackwell BB. The Prescriber’s Guide to the MAOI Diet-Thinking Through Tyramine Troubles. Psychopharmacol Bull. 2022;52(2):73-116.
